These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 7834397)

  • 1. Toxicity of sulfonamide-reactive metabolites in HIV-infected, HTLV-infected, and noninfected cells.
    Rieder MJ; Krause R; Bird IA; Dekaban GA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Feb; 8(2):134-40. PubMed ID: 7834397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential toxicity of reactive metabolites of clindamycin and sulfonamides in HIV-infected cells: influence of HIV infection on clindamycin toxicity in vitro.
    Wijsman JA; Dekaban GA; Rieder MJ
    J Clin Pharmacol; 2005 Mar; 45(3):346-51. PubMed ID: 15703369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.
    Rieder MJ; Uetrecht J; Shear NH; Spielberg SP
    J Pharmacol Exp Ther; 1988 Feb; 244(2):724-8. PubMed ID: 3346843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypersensitivity of HIV-1-infected cells to reactive sulfonamide metabolites correlated to expression of the HIV-1 viral protein tat.
    Arp J; Rieder MJ; Urquhart B; Freeman D; Tucker MJ; Krizova A; Lehmann D; Dekaban GA
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1218-25. PubMed ID: 15933158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of clarithromycin, fluconazole, and rifabutin on sulfamethoxazole hydroxylamine formation in individuals with human immunodeficiency virus infection (AACTG 283).
    Winter HR; Trapnell CB; Slattery JT; Jacobson M; Greenspan DL; Hooton TM; Unadkat JD
    Clin Pharmacol Ther; 2004 Oct; 76(4):313-22. PubMed ID: 15470330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is hydroxylamine-induced cytotoxicity a valid marker for hypersensitivity reactions to sulfamethoxazole in human immunodeficiency virus-infected individuals?
    Reilly TP; MacArthur RD; Farrough MJ; Crane LR; Woster PM; Svensson CK
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1356-64. PubMed ID: 10565861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methemoglobin formation by hydroxylamine metabolites of sulfamethoxazole and dapsone: implications for differences in adverse drug reactions.
    Reilly TP; Woster PM; Svensson CK
    J Pharmacol Exp Ther; 1999 Mar; 288(3):951-9. PubMed ID: 10027831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-course of toxicity of reactive sulfonamide metabolites.
    Rieder MJ; Krause R; Bird IA
    Toxicology; 1995 Jan; 95(1-3):141-6. PubMed ID: 7825180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro formation, disposition and toxicity of N-acetoxy-sulfamethoxazole, a potential mediator of sulfamethoxazole toxicity.
    Nakamura H; Uetrecht J; Cribb AE; Miller MA; Zahid N; Hill J; Josephy PD; Grant DM; Spielberg SP
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1099-104. PubMed ID: 7562475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of endogenous ascorbate and glutathione in the cellular reduction and cytotoxicity of sulfamethoxazole-nitroso.
    Lavergne SN; Kurian JR; Bajad SU; Maki JE; Yoder AR; Guzinski MV; Graziano FM; Trepanier LA
    Toxicology; 2006 May; 222(1-2):25-36. PubMed ID: 16473451
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione. Implications for idiosyncratic toxicity.
    Cribb AE; Miller M; Leeder JS; Hill J; Spielberg SP
    Drug Metab Dispos; 1991; 19(5):900-6. PubMed ID: 1686233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans.
    Farrell J; Naisbitt DJ; Drummond NS; Depta JP; Vilar FJ; Pirmohamed M; Park BK
    J Pharmacol Exp Ther; 2003 Jul; 306(1):229-37. PubMed ID: 12676884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8(+) cells by the hydroxylamine of sulfamethoxazole.
    Hess DA; Sisson ME; Suria H; Wijsman J; Puvanesasingham R; Madrenas J; Rieder MJ
    FASEB J; 1999 Oct; 13(13):1688-98. PubMed ID: 10506572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trimethoprim-sulfamethoxazole exposure alters ex vivo function of B lymphocytes isolated from human immunodeficiency virus-infected patients receiving Zidovudine.
    Venugopalan V; Thornton AC; Steinke DT; Rapp RP; Romanelli F; Feola DJ
    Pharmacotherapy; 2009 Apr; 29(4):373-82. PubMed ID: 19323617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis of sulfonamide hypersensitivity reactions by in-vitro "rechallenge" with hydroxylamine metabolites.
    Rieder MJ; Uetrecht J; Shear NH; Cannon M; Miller M; Spielberg SP
    Ann Intern Med; 1989 Feb; 110(4):286-9. PubMed ID: 2913915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical outcomes in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Horberg MA; Hurley LB; Klein DB; Follansbee SE; Quesenberry C; Flamm JA; Green GM; Luu T
    Arch Surg; 2006 Dec; 141(12):1238-45. PubMed ID: 17178967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The predictive value of the in vitro platelet toxicity assay (iPTA) for the diagnosis of hypersensitivity reactions to sulfonamides.
    Elzagallaai AA; Koren G; Rieder MJ
    J Clin Pharmacol; 2013 Jun; 53(6):626-32. PubMed ID: 23670648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the clinical, immunologic, and biochemical effects of nitroso sulfamethoxazole administration to dogs: a pilot study.
    Lavergne SN; Volkman EM; Maki JE; Yoder AR; Trepanier LA
    Toxicology; 2005 Mar; 208(1):63-72. PubMed ID: 15664433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell lymphotropic virus antibody prevalence in HIV-1-infected individuals attending a sexual health clinic in South-East London.
    Cooke FJ; Geretti AM; Zuckerman M
    J Med Virol; 2005 Jun; 76(2):143-5. PubMed ID: 15834880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exposure of mice to the nitroso metabolite of sulfamethoxazole stimulates interleukin 5 production by CD4+ T-cells.
    Hopkins JE; Naisbitt DJ; Humphreys N; Dearman RJ; Kimber I; Park BK
    Toxicology; 2005 Jan; 206(2):221-31. PubMed ID: 15588915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.